CYP 4.48% 32.0¢ cynata therapeutics limited

Ann: First Patient Treated in Phase 2 GvHD Trial, page-8

  1. 4,020 Posts.
    lightbulb Created with Sketch. 1364
    Hi Pledge,

    CYP management, have secured FDA approval, to run the trial in for aGVHD, as per the announcement and reported on Hot Copper.

    https://hotcopper.com.au/data/attachments/6014/6014093-14d780fd5de5a1e4ac79a00d14e82076.jpg
    Not like your beloved company, after 10 years, of trying haven't received any approval for anything, but taking those share holders for a ride to No Where.

    That why they are talking about class action against the company.

    IMHO.

    Regards

    Rossi70
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.015(4.48%)
Mkt cap ! $57.48M
Open High Low Value Volume
34.0¢ 34.0¢ 31.0¢ $167.6K 522.5K

Buyers (Bids)

No. Vol. Price($)
1 8217 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 5000 1
View Market Depth
Last trade - 15.59pm 03/06/2024 (20 minute delay) ?
Last
31.5¢
  Change
-0.015 ( 4.55 %)
Open High Low Volume
33.5¢ 33.5¢ 30.0¢ 100689
Last updated 14.55pm 03/06/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.